ew regimen of therapy in the treatment of human Brucellosis
Phase 2
- Conditions
- brucellosis.Brucellosis due to Brucella melitensis
- Registration Number
- IRCT2014041217230N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
After providing adequate information eligible patients volenteer will be enrolled in the study.
Patients who have received no treatment,Clinical signs and positive Blood culture,positive serological tests such as Wright and 2ME and Coombs Wright.
Exclusion criteria : pregnant women and children less than 8 years, patients with endocarditis, meningitis or spondylitis , Negative PCR tests are also excluded
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DNA of Brucella bacteria. Timepoint: Three sections: in first day of the study, end of the sixth week, end of the sixth month. Method of measurement: PCR.;Brucella bacteria. Timepoint: Three sections: in first day of the study, end of the sixth week, end of the sixth month. Method of measurement: Blood culture.;Antibody of serum. Timepoint: Before treatment, 6 weeks after begining of treatment, 6months after end of treatment. Method of measurement: Wright test, 2ME, Coombs.
- Secondary Outcome Measures
Name Time Method